Abstract
Pulmonary arterial hypertension (PAH) is an incurable, progressive disorder, and the early diagnosis and treatment of PAH are associated with increased survival [...].
Highlights
The patients’ ages were (mean ± standard deviation (SD)) 41.1 ± 15.7, 41.8 ± 13.7, and 50.2 ± 10.9, and the sex ratios of female/male (%) were 81.8/18.1, 83.3/16.7, and 72.7/27.3 for Pulmonary arterial hypertension (PAH) (n = 11), DM (n = 12), and heart (n = 11), respectively
The analysis of PAH samples versus DM or heart cohorts was assessed in two different runs, we found a very robust reproducibility of the metabolic data (Figure 2)
The analysis of PAH samples versus DM or heart cohorts was assessed in two different runJs. ,Clwin.eMfeodu. 2n01d9,a8,vxeFrOyRrPoEbEuRsRtErVeIEpWroducibility of the metabolic data (Figure 2)
Summary
A characteristic clustering of the PAH group, distinguishing them from DM and heart patients. The analysis of PAH samples versus DM or heart cohorts was assessed in two different runs, we found a very robust reproducibility of the metabolic data (Figure 2). We were able to combine two experiments using the PAH group as a reference point and compare all three patients’
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
